Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Galifa is a Swiss medical device company specializing in the design and manufacture of high-precision, custom-made contact lenses. Founded in 1980 and headquartered in St. Gallen, the company focuses on specialty vision care solutions for complex ocular conditions such as keratoconus, irregular corneas, and high astigmatism. Their product portfolio includes a wide range of gas permeable and soft contact lenses, as well as advanced orthokeratology lenses for overnight vision correction and myopia management. The company is recognized for its individual approach to lens geometry, catering to patients who cannot be fitted with standard mass-produced lenses. In 2022, Galifa was acquired by Contamac, a global leader in contact lens materials, to enhance its specialty lens manufacturing capabilities and expand its international reach.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Galifa.